92 related articles for article (PubMed ID: 1809075)
21. Quality control requirements in estrogen receptor determination.
Bojar H
Cancer Res; 1986 Aug; 46(8 Suppl):4249s-4250s. PubMed ID: 3524806
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
23. Comparison of immunochemical and radioligand binding assays for estrogen receptors in human breast tumors.
Di Fronzo G; Miodini P; Brivio M; Cappelletti V; Coradini D; Granata G; Ronchi E
Cancer Res; 1986 Aug; 46(8 Suppl):4278s-4281s. PubMed ID: 3524809
[TBL] [Abstract][Full Text] [Related]
24. An approach to preliminary studies of interlaboratory comparative results for estrogen and progesterone receptors.
Tubbs RR
J Cell Biochem Suppl; 1994; 19():36-9. PubMed ID: 7823603
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
26. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.
Leclercq G; Bojar H; Goussard J; Nicholson RI; Pichon MF; Piffanelli A; Pousette A; Thorpe S; Lonsdorfer M
Cancer Res; 1986 Aug; 46(8 Suppl):4233s-4236s. PubMed ID: 2425942
[TBL] [Abstract][Full Text] [Related]
27. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
28. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
Søreide JA; Lea OA; Kvinnsland S
Anticancer Res; 1991; 11(3):1323-6. PubMed ID: 1888167
[TBL] [Abstract][Full Text] [Related]
29. [Expression of estrogen receptors in breast cancer detected by various methods: lack of correlation].
Barbareschi M; Losi L; Capitanio G; Dittadi R; Gion M; Ludvìkovà M; Fina P; Dalla Palma P; Eusebi V
Pathologica; 1997 Aug; 89(4):397-404. PubMed ID: 9471608
[TBL] [Abstract][Full Text] [Related]
30. Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.
Koenders A; Thorpe SM
Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1221-9. PubMed ID: 6684569
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric steroid receptor analysis.
Schutte B; Scheres HM; De Goeij AF; Rousch MJ; Blijham GH; Bosman FT; Ramaekers FC
Prog Histochem Cytochem; 1992; 26(1-4):68-76. PubMed ID: 1484969
[No Abstract] [Full Text] [Related]
32. [Determination of estrogen receptors in 160 breast tumors using monoclonal antibodies: comparison of Abbott's immunoenzymatic method with the carbon dextran method].
Goussard J; Lechevrel C; Martin PM; Roussel G
Bull Cancer; 1985; 72(3):168-82. PubMed ID: 2416370
[TBL] [Abstract][Full Text] [Related]
33. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method.
Jarque F; Lluch A; Vizcarra E; Muñoz M; Alberola V; Garciá-Conde J
Oncology; 1994; 51(5):435-9. PubMed ID: 8052485
[TBL] [Abstract][Full Text] [Related]
34. Characterization of laboratory working standard for quality control of immunometric and radiometric estrogen receptor assays. Clinical evaluation on breast cancer biopsies. Italian Committee for Hormone Receptor Assays Standardization.
Piffanelli A; Pelizzola D; Giovannini G; Catozzi L; Faggioli L; Giganti M
Tumori; 1989 Dec; 75(6):550-6. PubMed ID: 2482565
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
Romain S; Lainé Bidron C; Martin PM; Magdelenat H
Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
[TBL] [Abstract][Full Text] [Related]
36. Quality control for estrogen and progesterone receptor assay in human breast cancer: the influence of computation methods on intra and interlaboratory variability.
Agrimonti F; Berruto GP; Fornaro D; De Bortoli M; Fumero S; Frairia R; Pelizzola D; Giovannini G; Piffanelli A
Tumori; 1985 Dec; 71(6):597-602. PubMed ID: 4082293
[TBL] [Abstract][Full Text] [Related]
37. External quality assessment of assays for hormones and tumor markers in Italian laboratories.
Zucchelli GC; Pilo A; Malvano R; Signorini C; Bolelli GF; Albertini A
Ann Ist Super Sanita; 1991; 27(3):479-86. PubMed ID: 1809068
[TBL] [Abstract][Full Text] [Related]
38. Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays.
Thorpe SM
Breast Cancer Res Treat; 1987; 9(3):175-89. PubMed ID: 2444291
[TBL] [Abstract][Full Text] [Related]
39. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
[No Abstract] [Full Text] [Related]
40. Estrogen and progesterone measurement and its quality control in breast cancer: a reappraisal.
Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M
Int J Biol Markers; 1986; 1(1):15-28. PubMed ID: 3320222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
